Caplin Point Labs News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Caplin Point Laboratories Ltd. authored by ICICI Direct and published by - Trendlyne research reports.
Item: Caplin Point Laboratories Ltd.
Rating: 5
Author: ICICI Direct

Keep track of all breaking news and updates on Caplin Point Labs from all sources in a single place.

Caplin Point Laboratories Ltd.

11 Feb 2026

1692.10

-0.71%

Earnings Call

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of the Earnings Call - Q3 - FY 2025-26

pdf

Caplin Point Laboratories Ltd.

06 Feb 2026

1692.10

-0.71%

Caplin Point Laboratories

Buy: Caplin Point Laboratories ...

Target

ICICI Direct

Caplin Steriles caters mainly to the US and other regulated markets. So far, it has developed and filed 52 ANDAs in the US on its own and with partners, with 42 approvals as on date. The Company is also working on a portfolio of 40+ simple and complex Injectable and Ophthalmic products,...

Number of FII/FPI investors decreased from 190 to 174 in Dec 2025 qtr

Caplin Point Laboratories Ltd.

05 Feb 2026

1692.10

-0.71%

to see Rapid results content

Caplin Point Laboratories Ltd.

05 Feb 2026

1692.10

-0.71%

Investor Presentation

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation for the quarter and nine months ended December 31, 2025

pdf

Caplin Point Laboratories Ltd.

05 Feb 2026

1692.10

-0.71%

Result

Caplin Point Laboratories Ltd - 524742 - Financial Results For The Quarter Ended December 31, 2025

BSE India

Unaudited standalone and Consolidated Financial Results for the Quarter and nine months ended December 31, 2025

pdf

	Dec 2025	Sep 2025	Dec 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	576.45	564.41	524.32	2.1%	9.9%
Operating Profit Qtr	189.69	189.17	162.29	0.3%	16.9%
Net Profit Qtr	163.88	154.45	138.96	6.1%	17.9%
Earning Per Share Adjusted latest Qtr	21.56	20.32	18.28	6.1%	17.9%

* Consolidated data

Detailed Results

Caplin Point Laboratories Ltd.

05 Feb 2026

1692.10

-0.71%

Board Meeting

Caplin Point Laboratories Ltd - 524742 - Board Meeting Outcome for Outcome Of Board Meeting

BSE India

Outcome of the Board Meeting held on February 05, 2026

pdf

Caplin Point Laboratories Ltd.

03 Feb 2026

1692.10

-0.71%

Company Update

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Appointment of Directors of the Company

pdf

Caplin Point Laboratories Ltd.

03 Feb 2026

1692.10

-0.71%

AGM

Caplin Point Laboratories Ltd - 524742 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

BSE India

Voting results and Scrutinizer report for the Postal Ballot dated January 31, 2026

pdf

Caplin Point Laboratories Ltd.

29 Jan 2026

1692.10

-0.71%

Company Update

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Analyst / investor Call for the quarter ended December 31, 2025

pdf

Caplin Point Laboratories Ltd.

27 Jan 2026

1692.10

-0.71%

Company Update

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release regarding receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for the ANDA Methylprednisolone Acetate Injectable Suspension USP.

pdf

Is Caplin Point Laboratories Ltd. worth buying?

491 Votes:

Buy 80.86%

Sell 12.22%

Hold 6.92%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf